Why Allucent?
Allucent was specifically built to meet the very unique needs of the small to mid-size biotech. Our range of capabilities is equivalent to that of large contract research organizations, but with the expertise and specialization of niche CROs. Through extraordinary attention to detail and focused operational efficiency we deliver to your milestones. We anticipate and mitigate problems before they happen and our nimble philosophy allows us to pivot to your needs quickly.
Therapeutic Proficiency
You treat the most complex and challenging diseases. We’ve assembled expert, multidisciplinary teams to support your specific therapeutic need.
Exceptional Clinical Trial Delivery
Allucent’s flexible clinical development and regulatory solutions enable our partners to successfully navigate the complexities of managing and conducting early and late-stage multi-national programs
Robust Consulting
From biostatistical consulting to regulatory strategy and clinical pharmacology, Allucent has a deep bench of experts to tackle these critically important gates to improve efficiencies and take your drug to market faster.
Clinical Pharmacology
Allucent’s clinical pharmacology team helps you meet key milestones with strategic planning, PK/PD studies, dose optimization, MIDD, and regulatory submissions. Our expertise accelerates timelines, improves decision-making, and mitigates risk.
Testimonials

Therapeutic Expertise
The Allucent Centers of Expertise (ACEs) are designed, structured, and resourced to deliver comprehensive trial and regulatory strategy; effective patient-focused recruitment plans; and solutions that meet your specific needs.
Leadership

About Us
A Fully Integrated Global Company
Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid-sized companies’ deep commitment to supporting breakthrough science by partnering with them to navigate the complexities of delivering novel treatments to patients.
With offices across North America, Europe, and the Middle East, Allucent has experience conducting trials in more than 75 countries, focusing on some of the most complex development areas. Globally, Allucent has worked on more than 825 clinical trials, with oncology representing the majority.
Frequently Asked Questions
A lot, actually. Allucent was specifically built to meet the very unique needs of the small to mid-size Biotech. Our range of capabilities is equivalent to that of large contract research organizations, but with the expertise and specialization of niche CROs. Through extraordinary attention to detail and focused operational efficiency we deliver to your milestones. We anticipate and mitigate problems before they happen and our nimble philosophy allows us to pivot to your needs quickly.
The most efficient and effective way to evaluate why Allucent is the best CRO for your drug development program is to click this link. It takes you to a form where you answer a few questions, then one of our A-Team experts will reach out to you within 24 hours. That kicks off a process where we get a comprehensive understanding of your needs, and we come back to you with a detailed proposal for how Allucent will be the best partner to ensure your success.
The Allucent brand is only 3 years old. In actuality, we’ve been around for almost 40 years. After a series of acquisitions and mergers, Allucent is purpose-built and the sum total of CATO Research (1988), SMS Oncology (1994), Pharm-Olam (2007), Nuventra (2008), Array Biostatistics (2012), and CATO-SMS (2019).
